1722-14-1

Basic information

• Product Name: 4-Chloro-6-piperidin-1-yl-pyrimidine
• Synonyms: 4-Chloro-6-piperidin-1-yl-pyrimidine;6-(PIPERIDIN-1-YL)-4-CHLOROPYRIMIDINE;4-chloro-6-piperidin-1-ylpyrimidine(SALTDATA: FREE)
• CAS NO: 1722-14-1
• Molecular Formula: C₉H₁₂ClN₃
• Molecular Weight: 197.66468
• Mol File: 1722-14-1.mol
• Article Data: 5

Chemical Properties

• Melting Point: 78-79℃
• Boiling Point: 341.4 °C at 760 mmHg
• Flash Point: 160.3 °C
• Appearance: /
• Density: 1.234 g/cm³
• Vapor Pressure: 8.05E-05mmHg at 25°C
• Refractive Index: 1.564
• CAS DataBase Reference: 4-Chloro-6-piperidin-1-yl-pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-6-piperidin-1-yl-pyrimidine(1722-14-1)
• EPA Substance Registry System: 4-Chloro-6-piperidin-1-yl-pyrimidine(1722-14-1)

Safety Data

• Hazardous Substances Data: 1722-14-1(Hazardous Substances Data)

Usage

General Description

4-Chloro-6-piperidin-1-yl-pyrimidine is a chemical compound with the molecular formula C8H12ClN3. It is a white to off-white solid that is insoluble in water but soluble in organic solvents. 4-Chloro-6-piperidin-1-yl-pyrimidine is often used as an intermediate in the synthesis of pharmaceutical compounds, agrochemicals, and other organic molecules. It has been shown to possess anti-cancer properties and is used in research and development of potential anti-cancer drugs. Additionally, it has been studied for its potential use as a herbicide and insecticide. 4-Chloro-6-piperidin-1-yl-pyrimidine is an important building block in the synthesis of various biologically active compounds and is used in a wide range of chemical and pharmaceutical applications.

InChI:InChI=1/C9H12ClN3/c10-8-6-9(12-7-11-8)13-4-2-1-3-5-13/h6-7H,1-5H2

Upstream product

• 110-89-4 piperidine 
• 1193-21-1 4,6-dichloropyrimidine 

Downstream Products

• 1312164-80-9 4-(2-methoxyphenyl)-6-(piperidin-1-yl)pyrimidine 

Relevant articles and documents

Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1

In our efforts to identify novel small molecule inhibitors for the treatment of adrenoleukodystrophy (ALD), we conducted a high-throughput radiometric screen for inhibitors of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. We developed a seri

Selective mono-amination of dichlorodiazines

A mild, easy-to-perform, and versatile method for the formation of aminochlorodiazines from reaction of several types of dichlorodiazines (i.e., pyridazines, pyrimidines, and pyrazines) with primary or secondary amines in ethanol in the presence of trieth

SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGICAL DISEASES

The invention relates to dihydropyrazolon-derivatives of formula (I), to methods for their production, to their use for treating and/or for preventing diseases and their use for producing medicaments for treating and/or for preventing diseases, in particular cardiovascular and haematological diseases, kidney diseases and for promoting the healing of wounds.